Buy or sell Mitra Biotech stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Mitra Biotech Stock

personalized cancer treatment

Founded

2009

Notable Investors

Sands Capital Ventures

Headquarters

Woburn MA, US

Total Funding

$74.5M

About Mitra Biotech Stock

Mitra is an innovative biotechnology company dedicated to discover tools to segregate patients for existing and developing anti-cancer treatments. Mitra is addressing significant challenges in personalized cancer medicine with dedicated scientists educated and trained in world famous institutes. Mitra’s discoveries to detect and manage cancer have practical applications and will be moved from the bench to bedside.

Investors

Funding History

April 2010$2.2M
October 2013$4.9M
August 2016$27.4M
July 2018$40.0M

Management

Chief Commercial Officer

Parker Cassidy

Co-Founder & CSO

Pradip Majumder

Co-Founder, President & CEO

Mallik Sundaram

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Mitra Biotech or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo